Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 03, 2024 08:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc.

NEWARK, Del, July 03, 2024 (GLOBE NEWSWIRE) -- The liposomal doxorubicin market is estimated to be worth USD 1,281.3 Million in 2024 and is projected to be valued at USD 2,367.5 Million in 2034....
October 27, 2022 07:05 ET | Source: Growth Plus Reports

Liposomal Doxorubicin Market to hit US$ 2.05 Billion by 2030 | Exclusive Report by Growth Plus Reports

Pune, Oct. 27, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Liposomal Doxorubicin Market by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), by...
May 04, 2022 19:00 ET | Source: FACT.MR

Rising Incidence of Cancer to Drive Doxorubicin Market at CAGR of 5.3% through 2026: Fact.MR Research

United States, Rockville MD, May 04, 2022 (GLOBE NEWSWIRE) -- According to a recently published Fact.MR report, the global Doxorubicin Market is projected to grow at a compound annual rate (CAGR) of...
July 09, 2021 08:40 ET | Source: CMI

Liposomal Doxorubicin Market in U.S. to Surpass US$ 192.9 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE, July 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. liposomal doxorubicin market is estimated to be valued at US$ 140.0 Million in 2020 and is expected to...